296 results on '"Pitini, Vincenzo"'
Search Results
2. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
3. 90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
4. Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
5. Use of Bisphosphonates in Oncology
6. Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study
7. Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature
8. Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease
9. Circulating mitotic figures in a patient with dual infection by Epstein–Barr virus and cytomegalovirus
10. Use of Bisphosphonates in Oncology
11. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia
12. HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy
13. Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases
14. Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma
15. Bisphosphonates associated osteonecrosis of the jaw: A longterm follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time
16. Salvage therapy for primary central nervous system lymphoma with 90Y-Ibritumomab and Temozolomide
17. Efficacy and Safety of Bortezomib in Patients With Plasma Cell Leukemia
18. An accessory spleen wrongly recognised as relapse by positron emission tomography
19. Efficacy of safety and bortezomib in patients with plasma cell leukemia
20. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation
21. Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib
22. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
23. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report
24. Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma
25. Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab
26. An unusual presentation of schistosomiasis
27. STAT6 activation correlates with cerebrospinal fluid IL‐4 and IL‐10 and poor prognosis in primary central nervous system lymphoma
28. STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma.
29. Interferon Alpha, the New Old Disease Modifying Agent for Philadelphia-Negative Myeloproliferative Neoplasms
30. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
31. 90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST
32. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
33. Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent
34. Efficacy and Safety Of Bendamustine In Combination With Rituximab For Elderly Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia. A Retrospective Multicenter Study
35. Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma
36. Secondary Leukemia in a non-Hodgkin's Lymphoma Patient Presenting as Myeloid Sarcoma of the Breast
37. Thyroid function, autoimmunity and nodules in hematological malignancies
38. Polycythemia vera and essential thrombocytemia treated with IFN-ALPHA2a: Evidence of a significant clinical activity and molecular response.
39. Should the Use of Surveillance Imaging in Diffuse Large B-Cell Lymphoma Be Discontinued?
40. Personalized Treatment of Early-Stage Non-Small-Cell Lung Cancer: The Challenging Role of EGFR Inhibitors
41. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
42. Temozolomide-induced shrinkage of a pituitary carcinoma
43. MYELODYSPLASTIC SYNDROMES DEVELOPING DURING IMATINIB THERAPY FOR GIST
44. Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options
45. Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience
46. Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time
47. Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma
48. ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER
49. Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate
50. Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.